Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)

NCT02262884 · SurgiQuest, Inc. · Updated 6 June 2016

What is being tested
SurgiQuest AirSeal Insufflation System (AIS); Conventional Insufflation System (CIS)
For
Subcutaneous Emphysema
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 189 people. The full rules are on the registry page.
Where
United States (3 sites)
When
Starts or started Oct 2014, ends March 2017. Registered 13 Oct 2014.
Results
None posted yet.

In the researchers' words

A MULTI-CENTER, PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY TO EVALUATE PHYSICIAN PREFERENCE RELATED TO THE USE OF THE SURGIQUEST AIRSEAL INSUFFLATION SYSTEM (AIS) VS. CONVENTIONAL INSUFFLATION SYSTEMS (CIS) FOR THE MANAGEMENT OF PNEUMOPERITONEUM DURING ROBOTIC PARTIAL NEPHRECTOMY
ClinicalTrials.gov, NCT02262884

Sites

  • Washington University School of MedicineSt Louis, Missouri, United States
  • Hackensack University Medical CenterHackensack, New Jersey, United States
  • Swedish Medical CenterSeattle, Washington, United States